LE WE PMID CA
Antineoplastic agents (BASKET)4229Antineoplastische Substanz (allg)

Antineoplastic agents (BASKET)

Digitalis

MTOR

2009  
1
Disulfide and multisulfide antitumor agents and their modes of action.
[19387571] Arch Pharm Res 32(3): 299-315 (2009)
2009  
2
How do anti-mitotic drugs kill cancer cells?
[19625502] J Cell Sci 122(Pt 15): 2579-85 (2009)
2008  
3
Cardiac glycosides as novel cancer therapeutic agents.
[18332483] Mol Interv 8(1): 36-49 (2008)
2008  
4
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
[18332481] Mol Interv 8(1): 22-7 (2008)
2009  
5
New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.
[20001804] Future Oncol 5(10): 1685-704 (2009)
2009  
6
Targeting mitotic fragility in cancer.
[19519201] Future Oncol 5(5): 613-5 (2009)
1998  
7
New antimetabolites in cancer chemotherapy and their clinical impact.
[9717984] Br J Cancer 78 Suppl 3(-): 1-7 (1998)
2009  
8
Novel agents on the horizon for cancer therapy.
[19278961] CA Cancer J Clin 59(2): 111-37 (2009)
2008  
9
Newer cytotoxic agents: attacking cancer broadly.
[18347161] Clin Cancer Res 14(6): 1610-7 (2008)
2000  
10
Mitochondrion as a novel target of anticancer chemotherapy.
[10880547] J Natl Cancer Inst 92(13): 1042-53 (2000)
1963  
11
Patterns of response of animal tumors to anticancer agents. A systematic analysis of the literature in experimental cancer chemotherapy--1945-1958.
[5339901] Cancer Res 23(5 Pt 2): 521-980 (1963)
1957  
12
The employment of combinations of drugs in the chemotherapy of neoplasia: a review.
[13460966] Cancer Res 17(7): 635-54 (1957)
1957  
13
Combination therapy of malignant tumors with ionizing radiations and chemicals; a review.
[13446840] Cancer Res 17(6): 551-66 (1957)
1953  
14
A review: on the mechanism of action of certain temporary anti-cancer agents.
[13082484] Cancer Res 13(8): 545-51 (1953)
1998  
15
Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapy.
[9761935] Pathol Oncol Res 4(3): 171-8 (1998)
2003  
16
Classical chemotherapy: mechanisms, toxicities and the therapeutic window.
[14508075] Cancer Biol Ther 2(4 Suppl 1): S2-4 (2003)
2006  
17
Recent developments in the clinical pharmacology of classical cytotoxic chemotherapy.
[16842376] Br J Clin Pharmacol 62(1): 27-34 (2006)
2006  
18
Drug development in oncology: classical cytotoxics and molecularly targeted agents.
[16842375] Br J Clin Pharmacol 62(1): 15-26 (2006)
2010  
19
Targeted delivery of microbubbles and nanobubbles for image-guided thermal ablation therapy of tumors.
[20420552] Expert Rev Med Devices 7(3): 303-6 (2010)
2009  
20
Recent advances in the development of polyamine analogues as antitumor agents.
[19534534] J Med Chem 52(15): 4551-73 (2009)
2010  
21
Dissecting variability in responses to cancer chemotherapy through systems pharmacology.
[20520606] Clin Pharmacol Ther 88(1): 34-8 (2010)
2008  
22
Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment.
[18440854] Drug Resist Updat 11(3): 63-76 (2008)
2010  
23
Chemotherapy agents: a primer for the interventional radiologist.
[22550380] Semin Intervent Radiol 27(4): 384-90 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • Antineoplastische Substanz (allg)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia